Journal
INTERNATIONAL JOURNAL OF NANOMEDICINE
Volume 16, Issue -, Pages 7517-7533Publisher
DOVE MEDICAL PRESS LTD
DOI: 10.2147/IJN.S333657
Keywords
brain targeting; nanocarriers; blood-brain barrier; nanotherapeutics; in-vivo
Funding
- Deanship of Scientific Research at Princess Nourah bint Abdulrahman University through the Fast-Track Path of Research Funding Program
Ask authors/readers for more resources
The emergence of nanotechnologies, such as nanocarriers and nanotherapeutics, has revolutionized treatment strategies with more efficacious drug delivery systems, particularly for targeting brain diseases. Various nanocarrier-based composites have been developed for drug targeting towards brain cells, with ongoing advancements in technologies and research in this area.
The advent of nanotechnologies such as nanocarriers and nanotherapeutics has changed the treatment strategy and developed a more efficacious novel drug delivery system. Various drug delivery systems are focused on drug-targeting of brain cells. However, the manifestation of the brain barrier is the main hurdle for the effective delivery of chemother-apeutics, ultimately causing treatment failure of various drugs. To solve this problem, various nanocarrier-based drug delivery system has been developed for brain targeting. This review outlines nanocarrier-based composites for different brain diseases and highlights nanocarriers for drug targeting towards brain cells. It also summarizes the latest developments in nanocarrier-based delivery systems containing liposomal systems, dendrimers, polymeric micelles, polymeric nanocarriers, quantum dots (QDs), and gold nanoparticles. Besides, the optimal properties of nanocarriers and therapeutic implications for brain targeting have been extensively studied. Finally, the potential applications and research opportunities for nano-carriers in brain targeting are discussed.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available